Head-to-head comparison of 68Ga-PSMA-11 PET/CT and mpMRI in the detection, intra-prostatic localization, and local extension of primary prostate cancer: A single-center imaging study with histopathology gold-standard.
68Ga-PSMA-11 PET/CT和mpMRI对原发性前列腺癌的检出、前列腺内定位和局部扩展的头对头比较:一项以组织病理学为金标准的单中心影像学研究
作者:Ida Sonni,et al
摘要号:193
时间:2月11日 10:00pm(CST)
177Lu-PSMA-617 (LuPSMA) versus cabazitaxel in metastatic castration-resistant prostate cancer (mCRPC) progressing after docetaxel: Updated results including progression-free survival (PFS) and patient-reported outcomes (PROs) (TheraP ANZUP 1603)
177Lu-PSMA-617(LuPSMA)对比卡巴他赛在多西他赛治疗后进展的转移性去势抵抗前列腺癌(mCRPC)中的治疗:包括无进展生存期(PFS)和患者报告结局(PROs)等结果更新(TheraP ANZUP 1603)
作者:Michael S. Hofman,et al
摘要号:6
时间:2月11日 11:00pm(CST)
Biomarker analysis from a randomized phase II study of olaparib with or without cediranib in men with metastatic castration-resistant prostate cancer (mCRPC)
奥拉帕利联合或不联合西地尼布治疗转移性去势抵抗前列腺癌(mCRPC)的随机Ⅱ期研究的生物标志物分析
作者:Rana R. McKay,et al
摘要号:7
时间:2月12日 03:15 am(CST)
Clinically advanced penile (pSCC) and male urethral (uSCC) squamous cell carcinoma: A comparative genomic profiling (CGP) study.
临床晚期阴茎癌(pSCC)和男性尿道鳞状细胞癌(uSCC):一项比较基因组图谱(CGP)的研究
作者:Philippe E. Spiess, et al
摘要号:2
时间:2月12日 09:55 pm(CST)
Socio-environmental conditions associated with geospatial clusters of urothelial carcinoma: A multi-institutional analysis.
与尿路上皮癌地理空间簇相关的社会环境条件:一项多机构分析
作者:Daniel C. Edwards,et al
摘要号:392
时间:2月13日 12:30 am(CST)
First results from the phase 3 CheckMate 274 trial of adjuvant nivolumab vs placebo in patients who underwent radical surgery for high-risk muscle-invasive urothelial carcinoma (MIUC).
针对高危肌层浸润性尿路上皮癌(MIUC)患者根治性手术后纳武利尤单抗对比安慰剂辅助治疗的3期CheckMate 274试验的首次结果
作者:Dean F. Bajorin,et al
摘要号:391
时间:2月13日 04:45 am(CST)
Peri-operative morbidity and mortality in a modern series of patients treated with cytoreductive nephrectomy (CN) at five centers.
在五个中心接受减瘤性肾切除术(CN)治疗的现代系列患者的围手术期发病率和死亡率
作者:Ashanda R. Esdaille,et al
摘要号:268
时间:2月13日 11:00 pm(CST)